DOCSLIB.ORG

Vol. 37, No. 1 January 2020 Yeungnam University Journal of Medicine Vol

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vol. 37, No. 1 January 2020 Yeungnam University Journal of Medicine Vol https://www.e-yujm.org eISSN 2384-0293 Vol. 37, No. 1 January 2020 Yeungnam University Journal of Medicine Yeungnam Vol. 37, No. 1 January 2020 Vol. pages 1-72 Yeungnam University College of Medicine Yeungnam University Institute of Medical Science e-yujm.org eISSN 2384-0293 Vol. 37 · No. 1 · January 2020 Aims and scope Yeungnam University Journal of Medicine (Yeungnam Univ J Med, YUJM, eISSN 2384-0293, https://www.e-yujm.org), the official publication of the Yeungnam University College of Medicine, is an international, peer-reviewed, and open access journal in the medical field. YUJM aims to communicate new medical information to medical personnel, and to facilitate the development of medicine and the propagation of medical knowledge by publishing high quality evidence-based articles. It covers all fields of medical science, including clinical research and basic medical science. YUJM publishes original articles, case reports, review articles, and editorials. All manuscripts should be creative, informative, and helpful for the diagnosis and treatment of medical diseases and for the communication of valuable information about all fields of medicine. The first volume was published in December 1984. YUJM is published in English, four times a year (January 31, April 30, July 31 and October 31). YUJM is indexed/tracked/covered by PubMed Central, PubMed, DOAJ, KoreaMed, Korea Citation Index, KoMCI, WPRIM, DOI/CrossRef, and Google Scholar. Open access This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Publisher Yeungnam University College of Medicine Editor-in-chief Joon Hyuk Choi, Yeungnam University College of Medicine Editorial office Yeungnam University College of Medicine 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea Tel: +82-53-640-6832 Fax: +82-53-651-0394 E-mail: [email protected] Printing office M2community Co. 8th FL, DreamTower, 66 Seongsui-ro, Seongdong-gu, Seoul 04784, Korea Tel: +82-2-2190-7300 Fax: +82-2-2190-7333 E-mail: [email protected] Published on January 31, 2020 Copyright © 2020 Yeungnam University College of Medicine This paper meets the requirements of KS X ISO 9706, ISO 9706-1994 and ANSI/NISO Z39. 48-1992 (Permanence of paper) Editorial board Editor-in-chief Joon Hyuk Choi Yeungnam University College of Medicine, Korea Associate editor Tae Gon Kim Yeungnam University College of Medicine, Korea Editorial board Kiwon Ban City University of Hong Kong, Hong Kong Min Cheol Chang Yeungnam University College of Medicine, Korea Du-Hyong Cho Yeungnam University College of Medicine, Korea Kyu Hyang Cho Yeungnam University College of Medicine, Korea Kwang Hae Choi Yeungnam University College of Medicine, Korea Jinmyoung Dan CHA University College of Medicine, Korea Kyung-Oh Doh Yeungnam University College of Medicine, Korea Jong Ryul Eun Hanyang University College of Medicine, Korea Mi Jin Gu Yeungnam University College of Medicine, Korea Geu-Ru Hong Yonsei University College of Medicine, Korea Ming-Yen Hsiao National Taiwan University College of Medicine, Taiwan Insoo Kang Yale University School of Medicine, USA Noriyuki Kanzaki Kobe University Graduate School of Medicine, Japan Jae Woon Kim Yeungnam University College of Medicine, Korea Ung Kim Yeungnam University College of Medicine, Korea Shaw Hua Anthony Kueh Auckland City Hospital, New Zealand Dong Shik Lee Yeungnam University College of Medicine, Korea Jae-Lyun Lee Ulsan University College of Medicine, Korea Keun Mi Lee Yeungnam University College of Medicine, Korea Yong Su Lim Gachon University College of Medicine, Korea Chul Hyun Park Yeungnam University College of Medicine, Korea Hosun Park Yeungnam University College of Medicine, Korea Jeong Hyun Park Kangwon National University College of Medicine, Korea So-young Park Yeungnam University College of Medicine, Korea Joon Sakong Yeungnam University College of Medicine, Korea In Hwan Song Yeungnam University College of Medicine, Korea Hoon-Ki Sung University of Toronto, Canada Kyu Chang Won Yeungnam University College of Medicine, Korea Wan-Hee Yoo Chonbuk National University College of Medicine, Korea Statistical editor Sang Won Kim Yeungnam University, Korea Keun Jung Ryu Yonsei Kim & Jung Hospital, Korea Managing editor Eunil Lee Yeungnam University College of Medicine, Korea Manuscript editor Hye-Min Cho InfoLumi, Korea Yoonjin Kim InfoLumi, Korea eISSN 2384-0293 Contents Vol. 37 · No. 1 · January 2020 Editorial 1 First step to international journal by indexing PMC and DOAJ Joon Hyuk Choi Review articles 2 Drug-induced liver injury Jeong Ill Suh 13 Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment Kyung Mi Jang 22 Reproductive toxic agents in work environments and related cases in Korea Chulyong Park Original articles 32 Nasal tip plasty using three-dimensional printed polycaprolactone (Smart Ball®) Joo Hyoung Kim, Geon Woo Kim, Won Kyung Kang 40 Correlation between anterior thigh pain and morphometric mismatch of femoral stem Haksun Chung, So Hak Chung 47 Clinical factors that affect the pregnancy rate in frozen-thawed embryo transfer in the freeze-all policy Seo Yoon Hwang, Eun Hye Jeon, Seung Chul Kim, Jong Kil Joo Case reports 54 Community-acquired Achromobacter xylosoxidans infection presenting as a cavitary lung disease in an immunocompetent patient Chan Hee Hwang, Woo Jin Kim, Hye Young Jwa, Sung Heon Song 59 Recurrent hemoptysis in a 26-year-old woman with a ground-glass opacity lesion of the lung Jong Ha Kim, Sin-Youl Park 63 Purulent pericarditis: subdiaphragmatic suppurative focus Kang-Un Choi, Chan-Hee Lee 67 Whole lung lavage using a rapid infusion system to treat a patient with pulmonary alveolar proteinosis Seung Won Ra, Soon Eun Park, Hyung Kwan Lee, Il Sang Han, Se Hun Park Copyright © 2020 Yeungnam University College of Medicine Editorial eISSN 2384-0293 Yeungnam Univ J Med 2020;37(1):1 https://doi.org/10.12701/yujm.2019.00395 First step to international journal by indexing PMC and DOAJ Joon Hyuk Choi Editor-in-Chief Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea Received: December 10, 2019 The Yeungnam University Journal of Medicine (YUJM) was first published in December 1984 as the offi- Revised: December 12, 2019 cial journal of the Yeungnam University College of Medicine. It is an international, peer-reviewed, and Accepted: December 13, 2019 open access journal. The aim of YUJM is to communicate new medical information to the medical per- Corresponding author: sonnel and facilitate the development of medicine through propagation of medical knowledge by publish- Joon Hyuk Choi ing high quality evidence-based articles. It has been published in English since 2018. Department of Pathology, YUJM has been indexed in both the Directory of Open Access Journals (DOAJ; June 2019) and Yeungnam University College of PubMed Central (PMC; October 2019). It has been available for journal article search through PubMed Medicine, 170 Hyeonchung-ro, Namgu, Daegu 42415, Korea since the publication of volume 35, issue 1, 2018. The significance of YUJM being indexed in DOAJ and Tel: +82-53-640-6754 PMC is as follows: firstly, it has advanced to an international-level journal; secondly, it can be easily Fax: +82-53-656-1429 searched in PubMed; and lastly, journal citations will increase because they are available online to be read E-mail: [email protected] and used readily. To promote YUJM to SCOPUS and SCIE-indexed journals, the efforts toward main- taining the high scientific standard of the journal need to be continued; additionally, there is a need to in- crease the critical mass and standard of content. Finally, I would like to express my sincere thanks to the former editor-in-chiefs, members of the editorial board, reviewers, manuscript editors, and publishers for their utmost devotion to the success of YUJM. In particular, I deeply appreciate all authors of the articles for their support and contribution. I hope that the readers and researchers will share their valuable thoughts and experiences, and recent information in the field of medical science. Acknowledgments Conflicts of interest No potential conflict of interest relevant to this article was reported. ORCID Joon Hyuk Choi, https://orcid.org/0000-0002-8638-0360 Copyright© 2020 Yeungnam University College of Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. https://doi.org/10.12701/yujm.2019.00395 1 Review article eISSN 2384-0293 Yeungnam Univ J Med 2020;37(1):2-12 https://doi.org/10.12701/yujm.2019.00297 Drug-induced liver injury Jeong Ill Suh Department of Internal Medicine, College of Medicine, Dongguk Unversity, Gyeongju, Korea Received: July 30, 2019 Revised: August 10, 2019 Drug-induced liver injury (DILI), including herbal and dietary supplement hepatotoxicity, is often Accepted: August 22, 2019 passed lightly; however, it can lead to the requirement of a liver transplant or may even cause death because of liver failure. Recently, the American College of Gastroenterology, Chinese Soci- Corresponding author: ety of Hepatology and European Association for the Study of the Liver guidelines for the diagno- Jeong Ill Suh Department of Internal Medicine, sis and treatment of DILI have been established, and they will be helpful for guiding clinical College of Medicine, Dongguk treatment decisions. Roussel Uclaf Causality Assessment Method scoring is the most commonly University, 87 Dongdae-ro, used method to diagnose DILI; however, it has some limitations, such as poor validity and repro- Gyeongju 38067, Korea ducibility. Recently, studies on new biomarkers have been actively carried out, which will help di- Tel: +82-54-770-8207 agnose DILI and predict the prognosis of DILI.
Load more

Recommended publications
  • Jeffrey Kleinberger Ph.D. Candidate Molecular Medicine Program, Genome Biology Track Graduate Program in Life Sciences, University of Maryland, Baltimore
    Discovery and Analysis of Patients with Monogenic Diabetes in Multiple Cohorts to Guide Future Diagnosis Item Type dissertation Authors Kleinberger, Jeffrey Publication Date 2017 Abstract Monogenic diabetes is hyperglycemia caused by a variant in a single gene, and it accounts for approximately 1-2% of all diabetes cases. A genetic diagnosis of monogenic diabetes is important because the most common gene etiologies can be effectively ... Keywords MODY; monogenic diabetes; screening; Clinical Trial; Diabetes Mellitus, Type 2; Zebrafish Download date 05/10/2021 09:00:42 Link to Item http://hdl.handle.net/10713/7072 Jeffrey Kleinberger Ph.D. Candidate Molecular Medicine Program, Genome Biology Track Graduate Program in Life Sciences, University of Maryland, Baltimore Contact Information Medical School Teaching Facility 357 685 West Baltimore St. Baltimore, MD 21201 [email protected] Education Juniata College Huntingdon, PA August 2004 – May 2008 Cum Laude distinction (GPA: 3.701) Biochemistry major Coursework included: Organic Chemistry, Bioinorganic Chemistry, Analytical Chemistry, Physical Chemistry, Chemistry Research, Biology, Cell Biology, Genetics, Biostatistics, Molecular Techniques, Physiology, Microbiology, Biochemistry and Molecular Biology (I-III), Calculus (I&II), Physics (I&II), Scientific Glassblowing, College Writing Seminar, Art of Public Speaking, Intro to Psychology, Learning & Conditioning, Mod. Knowledge & The Self, United States to 1877, The American Revolution, Survey of Western Art, Modern Architecture,
    [Show full text]
  • 一般演題（口演）/Oral Sessions
    一般演題（口演）!Oral Sessions ご ! 案 第 60 回大会賞候補セッション（口演） Oral Presentation Award Session 内 日 時：10 月 16 日（金）11：25～12：20 第 2 会場（南館 4 階 錦） 座 長：稲澤 譲治（東京医科歯科大学難治疾患研究所ゲノム応用医学研究部門（分子細胞遺伝）） 田中 敏博（東京医科歯科大学疾患バイオリソースセンター） Date：Oct. 16 （Fri.） 11：25～12：20 Room 2（Nishiki, South Tower 4F） Chairs：Johji Inazawa（Tokyo Medical and Dental University） Toshihiro Tanaka（Tokyo Medical and Dental University） プ ロ BO-1 ゲノムワイド関連解析（GWAS）データを活用した in silico 解析による新規抗パーキンソン病薬 グ の探索 ラ In silico drug discovery for Parkinson’s disease by using genome!wide association study ム （GWAS）data ○上中 健 1（Takeshi Uenaka）、佐竹 渉 1（Wataru Satake）、謝 珮琴 1（Pei"Chieng Cha）、 岡田 随象 2（Yukinori Okada）、戸田 達史 1（Tatsushi Toda） 1 神戸大学大学院医学研究科神経内科!分子脳科学 指 （Division of Neurology, Kobe University Graduate School of Medicine, Kobe, Japan） 定 2 東京医科歯科大学大学院医歯学総合研究科疾患多様性遺伝学分野 演 （Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, 題 Tokyo Medical and Dental University, Tokyo, Japan） 抄 録 BO-2 MIRAGE 症候群：機能亢進型 SAMD9 変異を原因とする新規症候群の発見 MIRAGE syndrome：New genetic syndrome caused by activating SAMD9 mutations ○鳴海 覚志 1（Satoshi Narumi）、天野 直子 1（Naoko Amano）、石井 智弘 1（Tomohiro Ishii）、 一 勝又 規行 2（Noriyuki Katsumata）、福澤 龍二 3（Ryuji Fukuzawa）、芝田 晋介 4（Shinsuke Shibata）、 般 4 5 6 演 岡野 栄之 （Hideyuki Okano）、清水 厚志 （Atsushi Shimizu）、三宅 紀子 （Noriko Miyake）、 題 松本 直通 6（Naomichi Matsumoto）、長谷川 奉延 1（Tomonobu Hasegawa） （ 1 慶應義塾大学医学部小児科 口 （Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan） 演 ） 2 国立成育医療研究センター研究所分子内分泌研究部 抄 （Department of Molecular Endocrinology, National Research
    [Show full text]
  • Mat Kadi Tora Tutti O Al Ut Hit Hitta Atuh
    MAT KADI TORA TUTTI USO AL20180235194A1 UT HIT HITTA ATUH ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0235194 A1 Fahrenkrug et al. (43 ) Pub . Date : Aug . 23, 2018 ( 54 ) MULTIPLEX GENE EDITING Publication Classification (51 ) Int. Ci. ( 71 ) Applicant: Recombinetics , Inc ., Saint Paul, MN A01K 67/ 027 (2006 . 01 ) (US ) C12N 15 / 90 ( 2006 .01 ) (72 ) Inventors : Scott C . Fahrenkrug, Minneapolis , (52 ) U . S . CI. MN (US ) ; Daniel F . Carlson , CPC .. .. A01K 67 / 0276 (2013 . 01 ) ; C12N 15 / 907 Woodbury , MN (US ) ( 2013 .01 ) ; A01K 67 /0275 ( 2013 .01 ) ; A01K 2267/ 02 (2013 .01 ) ; AOIK 2217 / 15 (2013 .01 ) ; AOIK 2227 / 108 ( 2013 .01 ) ; AOIK 2217 /07 (21 ) Appl. No. : 15 /923 , 951 ( 2013 .01 ) ; A01K 2227/ 101 (2013 .01 ) ; AOIK ( 22 ) Filed : Mar. 16 , 2018 2217 /075 ( 2013 .01 ) (57 ) ABSTRACT Related U . S . Application Data Materials and methods for making multiplex gene edits in (62 ) Division of application No . 14 /698 ,561 , filed on Apr. cells and are presented . Further methods include animals 28 , 2015, now abandoned . and methods of making the same . Methods of making ( 60 ) Provisional application No . 61/ 985, 327, filed on Apr. chimeric animals are presented , as well as chimeric animals . 28 , 2014 . Specification includes a Sequence Listing . Patent Application Publication Aug . 23 , 2018 Sheet 1 of 13 US 2018 / 0235194 A1 GENERATION OF HOMOZYGOUS CATTLE EDITED AT ONE ALLELE USING SINGLE EDITS Edit allele , Raise FO to Mate FO enough times Raise F1s to Mate F1 siblings Clone cell , sexual maturity , to produce enough F1 sexualmaturity , to make Implant, Gestate 2 years generation carrying 2 years homozygous KO , 9 months , birth edited allele to mate 9 months of FO with each other Generation Primary Fibroblasts ? ? ? Time, years FIG .
    [Show full text]
  • Beyond Type 1 and Type 2 Diabetes; Why Correct Diabetes Classification Is Important Gabriel I. Uwaifo, MD Dept of Endocrinology
    Beyond Type 1 and Type 2 Diabetes; Why Correct Diabetes Classification is Important Gabriel I. Uwaifo, MD, FACP, FTOS, FACE. Dept of Endocrinology, Diabetes, Metabolism and Weight Management, Ochsner Medical Center Objectives To highlight various classification methods of diabetes To highlight the importance and consequences of appropriate diabetes classification To provide suggested processes for diabetes classification in primary care settings and indices for specialty referral Presentation outline 1. Case presentations 2. Diabetes classification; past present and future 3. Diabetes classification; why is it important? 4. Suggested schemas for diabetes classification 5. Case presentation conclusions 6. Summary points and conclusions 3 Demonstrative cases Patient DL is a 56 yr old AA gentleman with a BMI of 24 referred for management of his “type 2 diabetes”. He is on basal bolus insulin with current HBA1c of 8.3. His greatest concern is on account of recent onset progressive neurologic symptoms and gaite unsteadiness Patient CY is a 21 yr old Caucasian lady with BMI of 28 and strong family history of diabetes referred for management of her “type 2 diabetes”. She is unsure if she even has diabetes as she indicates most of the SMBGs are under 160 and her current HBA1 is 6.4 on low dose metformin. Patient DR is a 54 yr old Asian lady with BMI of 36 and long standing “type 2 diabetes”. She has been referred because of poor diabetes control on multiple oral antidiabetics and persistent severe hypertriglyceridemia. Questions; Do all
    [Show full text]
  • An Interesting Case of Young Onset Diabetes Mellitus
    International Journal of Research in Medical Sciences Gulati S et al. Int J Res Med Sci. 2017 Sep;5(9):4178-4180 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20174007 Case Report An interesting case of young onset diabetes mellitus Shipra Gulati*, Tanvi Batra, Akshay A. Dhamne, Vijayashree S. Gokhale Department of Medicine, Dr. DY Patil Medical College and Hospital, Pimpri, Pune, Maharashtra, India Received: 23 June 2017 Accepted: 22 July 2017 *Correspondence: Dr. Shipra Gulati, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT A 24 years old female, was admitted with symptoms of urinary tract infection. She was married and had bad obstetric history. She was known diabetic for 16 years of age and was on regular treatment with injection human insulin mixtard since the time of diagnosis, but had no episode of diabetic ketosis/ ketoacidosis. She had a positive family history of diabetes. She was further evaluated and was found to have normal C peptide levels and islet cell antibodies were found to be negative. Hence, the possibility of MODY (monogenic diabetes) was considered. Her genetic testing could not be done due to financial constraints. But a trial of sulfonylureas was given along with reduction in the dose of insulin to which she responded well and is presently well controlled.
    [Show full text]
  • Servicios GENYCA 20171218 ENGLISH
    RARE DISEASES GENYCA_2018 TAT* CODE TEST OMIM ANALYSIS OF: GENES SAMPLE SPECIALITY (turnaraound time) 5 ml blood EDTA/Saliva SRD5A1-S Steroid 5-alpha-reductase *184753 cds SRD5A1 1 month Oncologic on swab 5 ml blood EDTA/Saliva ABL1-S ABL1, Gene *189980 cds ABL1 3 months Oncologic on swab 5 ml blood EDTA/Saliva GCDH-S Glutaric Acidemia Type I 231670 cds GCDH 4 weeks Metabolic on swab ACAT1, BCKDHA, BCKDHB, DBT, 251000, 251100, 251110, GCDH, HMGCL, IVD, MMAA, ACID-N Isolated Methylmalonic Acidemia 251120, 277410, 607481, cds 5 ml blood EDTA 3 months Metabolic MMAB, MMACHC, MCCC1, 607568, 608419, 609058 MCCC2, MUT, PCCA, PCCB 5 ml blood EDTA/Saliva SLC4A1-S Renal Tubular Distal Acidosis 611590 cds SLC4A1 6 weeks Hematologic on swab 5 ml blood EDTA/Saliva AUH-S 3-methylglutaconic aciduria, type I 250950 cds AUH 2 months Metabolic on swab 5 ml blood EDTA/Saliva IDH2-S D-2-hydroxyglutaric aciduria 2 613657 cds IDH2 6 weeks Multisystemic on swab ACYL-COA Dehydrogenase Medium-Chain, c.985A>G 5 ml blood EDTA/Saliva ACADM-V 201450 ACADM 1 month Metabolic Deficiency of (p.Lys304Glu) on swab ACYL-COA Dehydrogenase Medium-Chain, ACADM-S 201450 cds ACADM 5 ml blood EDTA 2 months Metabolic Deficiency of 5 ml blood EDTA/Saliva FGFR3-V Achondroplasia 100800 p.G380R, p.G375C FGFR3 2 weeks Musculoskeletal on swab 5 ml blood EDTA/Saliva ITGB2-S Leukocyte adhesion deficiency (LAD) 116920 cds ITGB2 2 months Hematologic on swab 5 ml blood EDTA/Saliva ADIPOQ-V Adiponectin (Hipoadiponectinemia) 612556 c.276G>T ADIPOQ 1 week Metabolic on swab ABCD1-D Adrenoleukodystrophy
    [Show full text]
  • Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
    Reviews/Commentaries/ADA Statements POSITION STATEMENT Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus 1 6 DAVID B. SACKS M. SUE KIRKMAN mellitus, formerly known as insulin- 2 7 MARK ARNOLD AKE LERNMARK 3 8 dependent diabetes mellitus (IDDM) or GEORGE L. BAKRIS BOYD E. METZGER 4 9 juvenile-onset diabetes mellitus, is usu- DAVID E. BRUNS DAVID M. NATHAN 5 ally caused by autoimmune destruction ANDREA RITA HORVATH of the pancreatic islet b-cells, rendering the pancreas unable to synthesize and se- crete insulin (2). Type 2 diabetes mellitus, BACKGROUND—Multiple laboratory tests are used to diagnose and manage patients with diabetes mellitus. The quality of the scientific evidence supporting the use of these tests varies formerly known as non-IDDM or adult- substantially. onset diabetes, is caused by a combina- tion of insulin resistance and inadequate APPROACH—An expert committee compiled evidence-based recommendations for the use of insulin secretion (3,4). Gestational diabe- laboratory testing for patients with diabetes. A new system was developed to grade the overall quality tes mellitus (GDM), which resembles type of the evidence and the strength of the recommendations. Draft guidelines were posted on the fi 2diabetesmorethantype1,develops Internet and presented at the 2007 Arnold O. Beckman Conference. The document was modi ed in during approximately 7% (range, 5%– response to oral and written comments, and a revised draft was posted in 2010 and again modified in response to written comments. The National Academy of Clinical Biochemistry and the Evidence- 15%) of pregnancies, usually remits after Based Laboratory Medicine Committee of the American Association for Clinical Chemistry jointly delivery, and constitutes a major risk fac- reviewed the guidelines, which were accepted after revisions by the Professional Practice Committee tor for the development of type 2 diabetes and subsequently approved by the Executive Committee of the American Diabetes Association.
    [Show full text]
  • Abstracts of Lectures Gfh ÖGH SGMG Tagungsband Abstracts
    patients were significantly different across pop mosomal level, but not generally at both levels. Abstracts of Lectures ulations with frequency maximum of the com In this view, the aneuploid karyotype is the read mon mutations in EastEurope (W151X, V326L), out of an underlying chromosomal instability NorthWestEurope (IVS81G>C), and SouthEu (CIN). In a small proportion of cancers display 1. Symposia rope (T93M). ing CIN the loss of this checkpoint is associated Carrier frequency analysis of the IVS81G>C, with the mutational inactivation of a human ho W151X, T93M, and V326L mutations in 2250 mologue of the yeast BUB1 gene. BUB1 controls S1 healthy individuals from different European pop mitotic checkpoints and chromosome segrega ulations revealed much higher frequencies for tion in yeast. The Human SHOX Mutation Database these common mutations (e.g. 1:50 for the IVS8 Because the MIN and CIN forms of instability are Beate Niesler, Christine Fischer and Gudrun A. 1G>C in Austria, and 1:84 for the W151X in rarely found to coexist in tumours, it would seem Rappold Poland) than expected from the reported preva that one form of instability is sufficient to drive Institute of Human Genetics, University of lence of the SLOS. Based on these frequencies tumorigenesis. Heidelberg, Im Neuenheimer Feld 328, the expected incidence of SLOS patients with Genetic instability appears early in tumorigene 69120 Heidelberg, Germany null mutations ranges from 1:2000 to 1:16.000. sis and is believed to play a critical role in the The human SHOX gene (Short Stature Home This discrepancy might be due to underdiagno malignant process.
    [Show full text]
  • Of Analyses January 2019 Imprint
    Index of Analyses January 2019 Imprint We reserve the right for errors and alterations. Our laboratory is part of the SYNLAB group. © 3rd edition By SYNLAB Medizinisches Versorgungszentrum Humane Genetik Medical Practice and Laboratory for Human genetics 2 Medical Director Dr. med. Dr. rer. nat. Claudia Nevinny-Stickel-Hinzpeter Consultant Human geneticist Postal Address Lindwurmstrasse 23 D-80337 Munich / Germany Telephone and Fax Reception +49 (0)89. 54 86 29 -0 Invoicing -0 Fax -243 Molecular Genetics -554 Cytogenetics -559 Office hours Monday – Friday 8.30 – 18.00 [email protected] www.humane-genetik.de 3 Table of contents Preanalytics 5 Molecular genetic analyses 8 Cardiac diseases 8 Complex syndromes 13 Connective Tissue Disorders 23 Endocrinology 26 Eye diseases 29 Fertility disorders 30 Gastrointestinal diseases 32 Hematology 33 Hemophilia 35 Hereditary cancer syndromes 36 Immune disorders 44 Intersexuality 45 Kidney diseases 46 Liver diseases 48 Lung diseases 50 Metabolic diseases 51 Mitochondrial diseases 61 Neurodegenerative diseases 64 Neuromuscular diseases /Neuropathies 69 Nutrigenetics 74 Pancreatic diseases 75 Periodic fever 76 Pharmacogenetics 80 Short stature 82 Thrombophilia/Atherosclerosis 84 Uniparental disomies 90 Kinship Analyses 91 Cytogenetics and molecular cytogenetics 92 Prenatal chromosome diagnostics 92 Postnatal chromosome diagnostics 94 Molecular cytogenetics 96 Chromosomal microarray diagnostics 99 Quality assurance 100 Index 104 Index gene names 116 4 Preanalytics Testing Material For genetic testing nuclei-containing cells of the patient are required, which are either cultivated or subjected to DNA extraction. Cells can be harvested from peripheral blood, buccal swabs, amniotic fluid, chorionic villi (CVS), or tissue samples. In case of blood collection, no special preparation of the patient, e.g.
    [Show full text]
  • At the Staff Meeting of the Department of Pediatrics №4
    Ministry of Health of Ukraine Bogomolets National Medical University “APPROVED” At the staff meeting of the Department of pediatrics №4 Chief of the Department of Pediatrics №4 Academician, Professor, MD, PhD Maidannyk V.G. __________________________(Signature) “_____” ___________________ 2020 y. Methodological recommendations for students Subject Pediatrics, Children’s infectious diseases. Module 1 Pediatrics Topic Thyroid gland diseases in children. Course 5 Faculty Medical №2 Kyiv -2020 1 AUTHORSHIP Head of the Department - Doctor of Medical Sciences, MD, PhD, Academician of the NAMS of Ukraine Professor V.G. Maidannyk; MD, PhD, Associate Professor Ie.A. Burlaka; MD, PhD, Associate Professor R.V. Terletskiy; MD, PhD, Associate Professor O.S. Kachalova O.S.; MD, PhD Assistant T.D. Klets; MD, PhD Assistant T.A. Shevchenko. Topic: Thyroid gland diseases in children. Classification of thyroid diseases in children. Etiology, pathogenesis, clinical presentation, diagnostics, differential diagnostics, treatment, prophylaxis of diffuse toxic goiter, hypothyroidism, autoimmune thyroiditis, Prognosis. І. Topic Relevance. Thyroid functions disturbances is the common state among children. Thyroid diseases is quite various in children age. Thyroid diseases problems are the main relating to Chernobyl disaster because of morbidity increasing among children in autoimmune thyroiditis, hypothyroidism, good- quality and malignant tumors of thyroid. One of major places occupies congenital hypothyroidism that meets in frequency of 1 case to 5000 newborns. Congenital hypothyroidism in 85 – 90% of cases is primary and related to the iodine deficit or thyroid dysgenesis. Thus, the aplasia, hypogenesis or dystopia of thyroid are the more frequent states. Primary hypothyroidism in 5 – 10% of cases unconditioned by dyshormonose (autosomal – recessive inheritance).
    [Show full text]
  • Genetic Epidemiology of Diabetes M
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2005 Genetic epidemiology of diabetes M. Alan Permutt Washington University School of Medicine in St. Louis Jonathon Wasson Washington University School of Medicine in St. Louis Nancy Cox University of Chicago Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Permutt, M. Alan; Wasson, Jonathon; and Cox, Nancy, ,"Genetic epidemiology of diabetes." The ourJ nal of Clinical Investigation.,. 1431-1439. (2005). https://digitalcommons.wustl.edu/open_access_pubs/1460 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Downloaded on June 9, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/24758 Review series Genetic epidemiology of diabetes M. Alan Permutt,1 Jonathon Wasson,1 and Nancy Cox2 1Department of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, Missouri, USA. 2Department of Human Genetics, The University of Chicago, Chicago, Illinois, USA. Conventional genetic analysis focuses on the genes that account for specific phenotypes, while traditional epide- miology is more concerned with the environmental causes and risk factors related to traits. Genetic epidemiology is an alliance of the 2 fields that focuses on both genetics, including allelic variants in different populations, and environment, in order to explain exactly how genes convey effects in different environmental contexts and to arrive at a more complete comprehension of the etiology of complex traits.
    [Show full text]
  • Endocrine Test Selection and Interpretation
    The Quest Diagnostics Manual Endocrinology Test Selection and Interpretation Fourth Edition The Quest Diagnostics Manual Endocrinology Test Selection and Interpretation Fourth Edition Edited by: Delbert A. Fisher, MD Senior Science Officer Quest Diagnostics Nichols Institute Professor Emeritus, Pediatrics and Medicine UCLA School of Medicine Consulting Editors: Wael Salameh, MD, FACP Medical Director, Endocrinology/Metabolism Quest Diagnostics Nichols Institute San Juan Capistrano, CA Associate Clinical Professor of Medicine, David Geffen School of Medicine at UCLA Richard W. Furlanetto, MD, PhD Medical Director, Endocrinology/Metabolism Quest Diagnostics Nichols Institute Chantilly, VA ©2007 Quest Diagnostics Incorporated. All rights reserved. Fourth Edition Printed in the United States of America Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. All third party marks − ®' and ™' − are the property of their respective owners. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, and information storage and retrieval system, without permission in writing from the publisher. Address inquiries to the Medical Information Department, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA 92690-6130. Previous editions copyrighted in 1996, 1998, and 2004. Re-order # IG1984 Forward Quest Diagnostics Nichols Institute has been
    [Show full text]